Literature DB >> 22476402

Nonsebaceous lymphadenoma of salivary glands: proposed development from intraparotid lymph nodes and risk of misdiagnosis.

Christoph Weiler1, Abbas Agaimy, Pamela Zengel, Johannes Zenk, Thomas Kirchner, Stephan Ihrler.   

Abstract

Nonsebaceous lymphadenoma (NSLA) is a rare benign salivary gland tumor composed of lymphoid and epithelial components. By definition, the epithelial component lacks sebaceous differentiation and instead displays a wide range of histological differentiation. In this study, we have collected nine cases of NSLA to characterize their histological and immunohistochemical profiles. The samples were histologically reviewed and immunohistochemical stains for CK5/6, CK7, CK14, CK18, p63, and Ki67 performed. Patients were six males and three females (mean age, 50 years). All tumors were located in the parotid gland and showed intimate intermingling of lymphoid tissue with islands or strands of epithelium with a wide spectrum of histological differentiation. The immunohistochemical profiles mirrored the epithelial differentiation; hence, areas with basaloid or lymphoepithelial differentiation strongly expressed CK5/6, CK14, and p63, while areas with ductal differentiation showed strong positivity for CK18/CK7 and CK5/6/CK14/p63 in luminal and basal cell layers, respectively. A hilus structure with salivary inclusions or D2-40 (podoplanin)-positive marginal sinus was identifiable in four and nine of the cases, respectively, supporting origin within intra-/periparotid lymph nodes. Six cases were initially misdiagnosed as other benign (n = 4) or malignant tumors (n = 2). Our study on the second largest series of NSLA reported to date provides strong evidence that NSLA belongs to the group of salivary gland tumors that pathogenetically develop from embryonic salivary gland inclusions in intra-/periparotid lymph nodes. Knowledge of the wide histological spectrum of this rare and presumably underreported tumor is important in order to avoid misdiagnosis, particularly as malignant tumor.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22476402     DOI: 10.1007/s00428-012-1225-z

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  19 in total

Review 1.  [Lymphadenoma of the parotid gland without sebaceous differentiation. Immunohistochemical investigations].

Authors:  I Bos; S Meyer; H Merz
Journal:  Pathologe       Date:  2004-02       Impact factor: 1.011

Review 2.  Lymphadenoma of the salivary gland: a rare tumour.

Authors:  N B Musthyala; S E Low; R H Seneviratne
Journal:  J Clin Pathol       Date:  2004-09       Impact factor: 3.411

3.  Lymphoepithelial duct lesions in Sjögren-type sialadenitis.

Authors:  S Ihrler; C Zietz; A Sendelhofert; A Riederer; U Löhrs
Journal:  Virchows Arch       Date:  1999-04       Impact factor: 4.064

4.  Non-sebaceous lymphadenoma of the salivary gland: case report with immunohistochemical investigation.

Authors:  Shaodong Yang; Xinming Chen; Li Wang; Jiali Zhang
Journal:  Virchows Arch       Date:  2007-03-13       Impact factor: 4.064

Review 5.  [Primary salivary gland tumors in lymph nodes of the parotid gland. Report of 3 cases and review of the literature].

Authors:  G Seifert
Journal:  Pathologe       Date:  1997-03       Impact factor: 1.011

6.  Sebaceous neoplasms of salivary gland origin. Report of 21 cases.

Authors:  D R Gnepp; R Brannon
Journal:  Cancer       Date:  1984-05-15       Impact factor: 6.860

7.  Tumor-associated lymphoid proliferation in the parotid gland. A potential diagnostic pitfall.

Authors:  P L Auclair
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1994-01

8.  Lymphadenoma arising in the parotid gland: a case report.

Authors:  Ghee Young Kwon; Eo-Jin Kim; Jai Hyang Go
Journal:  Yonsei Med J       Date:  2002-08       Impact factor: 2.759

9.  Lymphadenoma lacking sebaceous differentiation in the parotid gland.

Authors:  Julia Yu-Fang Chang; Cheng-Hsiang Hsiao
Journal:  J Formos Med Assoc       Date:  2004-06       Impact factor: 3.282

10.  Nonsebaceous lymphadenoma of the parotid gland: cytopathologic findings and differential diagnosis.

Authors:  Shobha Castelino-Prabhu; Qing Kay Li; Syed Z Ali
Journal:  Diagn Cytopathol       Date:  2010-02       Impact factor: 1.582

View more
  7 in total

1.  Salivary Intraductal Carcinoma Arising within Intraparotid Lymph Node: A Report of 4 Cases with Identification of a Novel STRN-ALK Fusion.

Authors:  Lisa M Rooper; Lester D R Thompson; Jeffrey Gagan; Bahram R Oliai; Ilan Weinreb; Justin A Bishop
Journal:  Head Neck Pathol       Date:  2020-07-13

Review 2.  [Updates on tumours of the salivary glands : 2017 WHO classification].

Authors:  S Ihrler; O Guntinas-Lichius; C Haas; M Mollenhauer
Journal:  Pathologe       Date:  2018-02       Impact factor: 1.011

3.  Non-sebaceous lymphadenoma of the lacrimal gland: first report of a new localization.

Authors:  Mauro Pau; Luka Brcic; Raja R Seethala; Angelika K Klein-Theyer; Marton Magyar; Knut E Reinbacher; Michael Schweiger; Jürgen Wallner; Norbert Jakse
Journal:  Virchows Arch       Date:  2018-02-19       Impact factor: 4.064

4.  Malignant Transformation of Parotid Gland Non-sebaceous Lymphadenoma: Case Report and Review of Literature.

Authors:  Hakan Kara; Said Sönmez; Sidar Bağbudar; Mine Güllüoğlu; Bora Başaran
Journal:  Head Neck Pathol       Date:  2020-01-29

Review 5.  [Cutaneous adnexal and salivary gland tumours. Similarities and differences].

Authors:  S Ihrler; C Weiler; F Eckert; M Mollenhauer
Journal:  Pathologe       Date:  2014-09       Impact factor: 1.011

6.  Low Molecular Weight Cytokeratin Immunohistochemistry Reveals That Most Salivary Gland Warthin Tumors and Lymphadenomas Arise in Intraparotid Lymph Nodes.

Authors:  Anne C McLean-Holden; Justin A Bishop
Journal:  Head Neck Pathol       Date:  2020-08-31

7.  Lymphadenoma of the salivary gland: Report of 10 cases.

Authors:  Guanglong Liu; Jie He; Chunye Zhang; Shuiting Fu; Yue He
Journal:  Oncol Lett       Date:  2014-01-24       Impact factor: 2.967

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.